Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The dosing framework on this page is based on the published Phase 2 trial (Jastreboff et al., 2023, NEJM ) and the Rosenstock et al
Int J Nanomed 12:82398255
Epithalon and Tumor Growth Daily administration of epithalon to rats with cancer has been found to decrease tumor growth[]
Research suggests that combining CJC-1295 and Ipamorelin may increase growth hormone (GH) release more than either peptide alone
Rubin MR, Volek JS, Gmez AL, Ratamess NA, French DN, Sharman MJ, et al
US$ 29.83
US$ 29.55
US$ 29.80
